Evaluation of Safety and Efficacy of Etodolac Injection in Patients with Post-Operative Orthopedic Pain.
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 13 Nov 2019
Price : $35 *
At a glance
- Drugs Etodolac (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Ipca Laboratories
- 05 Nov 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Jul 2017 Status changed from not yet recruiting to recruiting.
- 04 May 2017 New trial record